Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
ADC Therapeutics
ADC Therapeutics
(ADCT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zynlonta
Loncastuximab tesirine
2021-04-23
Large b-cell lymphoma diffuse
,
B-cell lymphoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Loncastuximab tesirine
b-cell chronic lymphocytic leukemia
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
burkitt lymphoma
,
central nervous system neoplasms
,
follicular lymphoma
,
mantle-cell lymphoma
,
non-hodgkin lymphoma
,
waldenstrom macroglobulinemia
,
b-cell lymphoma marginal zone
,
recurrence
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
hodgkin disease
Epratuzumab
leukemia
,
large b-cell lymphoma diffuse
,
follicular lymphoma
,
lymphoid leukemia
,
mantle-cell lymphoma
,
waldenstrom macroglobulinemia
,
b-cell lymphoma
,
b-cell chronic lymphocytic leukemia
,
b-cell lymphoma marginal zone
,
large-cell lymphoma immunoblastic
,
philadelphia chromosome
,
recurrence
,
aggression
,
lymphoma
,
systemic lupus erythematosus
,
non-hodgkin lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
burkitt lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
t-cell lymphoma peripheral
Edrecolomab
healthy volunteers/patients
,
neoplasms
,
ovarian neoplasms
,
prostatic neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
,
biliary tract neoplasms
,
colorectal neoplasms
,
urinary bladder neoplasms
,
leukemia
,
lymphoma
,
b-cell leukemia
,
chronic obstructive pulmonary disease
Calcium dobesilate
leukemia
,
hematologic neoplasms
,
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
Lornoxicam
b-cell lymphoma
,
burkitt lymphoma
,
precursor b-cell lymphoblastic leukemia-lymphoma
,
leukemia
,
t-cell lymphoma peripheral
,
lymphoid leukemia
,
osteosarcoma
,
neoplasm metastasis
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
ovarian neoplasms
,
triple negative breast neoplasms
,
glioblastoma
,
glioma
,
astrocytoma
,
neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
neuroblastoma
,
diffuse intrinsic pontine glioma
,
sarcoma
,
medulloblastoma
,
rhabdoid tumor
,
ewing sarcoma
,
rhabdomyosarcoma
,
waldenstrom macroglobulinemia
,
large b-cell lymphoma diffuse
,
recurrence
,
systemic scleroderma
,
skin diseases
,
diffuse scleroderma
,
hodgkin disease
,
multiple myeloma
,
breast neoplasms
,
lymphoma
,
non-hodgkin lymphoma
,
adenocarcinoma
,
mantle-cell lymphoma
,
follicular lymphoma
,
myeloid leukemia acute
,
residual neoplasm
,
rheumatoid arthritis
,
obesity
,
arthritis
Bevifimod
sickle cell anemia
,
neoplasms
,
colonic neoplasms
,
adenocarcinoma
,
systemic lupus erythematosus
,
colorectal neoplasms
,
agammaglobulinemia
,
primary immunodeficiency diseases
,
von willebrand diseases
,
alzheimer disease
,
graft vs host disease
,
thrombocytopenic purpura idiopathic
,
protein c deficiency
,
leukemia
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
hodgkin disease
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
mantle-cell lymphoma
,
myeloid leukemia chronic-phase
,
large b-cell lymphoma diffuse
,
myeloid leukemia accelerated phase
,
burkitt lymphoma
,
large-cell lymphoma immunoblastic
,
hemophilia b
,
thrombotic thrombocytopenic purpura
,
chronic obstructive pulmonary disease
,
dementia
,
mucocutaneous lymph node syndrome
,
immunologic deficiency syndromes
,
hemophilia a
,
alpha 1-antitrypsin deficiency
,
disease
,
healthy volunteers/patients
CAMIDANLUMAB
renal cell carcinoma
,
carcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
urinary bladder neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
myeloid leukemia
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
myeloid leukemia acute
,
hodgkin disease
,
myelodysplastic syndromes
,
myeloproliferative disorders
,
myelodysplastic-myeloproliferative diseases
,
lymphoma
CAMIDANLUMAB TESIRINE
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
renal cell carcinoma
,
carcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
triple negative breast neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
breast neoplasms
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
myeloid leukemia
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
myeloid leukemia acute
,
hodgkin disease
,
myelodysplastic syndromes
,
myeloproliferative disorders
,
myelodysplastic-myeloproliferative diseases
,
lymphoma
Loncastuximab
b-cell chronic lymphocytic leukemia
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
burkitt lymphoma
,
central nervous system neoplasms
,
follicular lymphoma
,
mantle-cell lymphoma
,
non-hodgkin lymphoma
,
waldenstrom macroglobulinemia
,
b-cell lymphoma marginal zone
,
recurrence
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
hodgkin disease
Nepidermin
melanoma
,
merkel cell carcinoma
,
neoplasm metastasis
,
non-small-cell lung carcinoma
,
parkinson disease
,
dyskinesias
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
hepatitis c
,
glioblastoma
,
systemic lupus erythematosus
,
psoriatic arthritis
,
psoriasis
,
arthritis
,
hiv infections
,
lipodystrophy
,
breast neoplasms
,
lung neoplasms
Odronextamab
hodgkin disease
,
b-cell lymphoma
Palifosfamide
sarcoma
,
rhabdomyosarcoma
,
lymphoma
Globulin, immune
colorectal neoplasms
,
pancreatic neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
gastrointestinal stromal tumors
,
rectal neoplasms
,
mantle-cell lymphoma
,
reactive arthritis
,
lymphoma
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
follicular lymphoma
,
hodgkin disease
,
sclerosis
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
leukemia
,
multiple sclerosis
Anthracycline
prostatic neoplasms
,
radiation injuries
Aminoglycoside
neoplasms
,
neoplasms by histologic type
,
connective and soft tissue neoplasms
,
leiomyosarcoma
,
breast neoplasms
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
myeloid leukemia acute
,
plasmablastic lymphoma
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
lymphoma
,
multiple myeloma
,
plasma cell neoplasms
,
b-cell lymphoma
,
sarcoma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
mantle-cell lymphoma
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
circulating neoplastic cells
,
fibrosis
,
cystic fibrosis
,
acute kidney injury
,
head and neck neoplasms
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use